Ithaca Energy acquires Valiant Petroleum

Valiant Petroleum's shared soared by nearly 30 per cent Friday after Ithaca Energy announced it would acquire the company for 203m pounds.

Valiant Petroleum's shared soared by nearly 30 per cent Friday after Ithaca Energy announced it would acquire the company for 203m pounds.

The acquisition will more than double Ithaca's 2013 production forecast to 14,000 to 16,000 barrels of oil equivalent per day. However Ithaca's shares fell 10% in early morning trading.

Valiant has a portfolio of production, development and exploration assets in the UK and Norway.

Under the offer, Valiant shareholders will be entitled to receive 307p in cash and 1.33 Ithaca consideration shares for each Valiant share.

The deal represents a premium of 37% to Valiant's closing price of 346p per share Thursday on the London Stock Exchange.

It comes after Valiant put itself up for sale in September as part of a strategic review.

Ithaca had also received a number of offers.

The completion of the transaction is subject to shareholder and regulatory approval.

In a separate announcement, Valiant said it has completed drilling of the Timon prospect in the UK's North Sea.

The company reported that the Upper Jurassic sands located in the area of the UK Northern North Sea known as blocks 211/11b and 211/16b had been found to be poorly developed in the target location.

The company said that the well would be plugged and abandoned as a dry hole.

The partners in the P1633 licence are MPX North Sea Limited, Agora Oil & Gas (UK) Limited a wholly owned subsidiary of Cairn Energy, Taqa Bratani, Wintershall E&P, Sorgenia E&P (UK) and Valiant Causeway.

RD

Recommended

Imperial Brands has an 8.3% yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% yield – but what’s the catch?

Tobacco company Imperial Brands boasts an impressive dividend yield, and the shares look cheap. But investors should beware, says Rupert Hargreaves. H…
20 May 2022
Investing in drugmakers: uncommon profits from curing rare diseases
Share tips

Investing in drugmakers: uncommon profits from curing rare diseases

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022
Delivering profits: should you buy Royal Mail shares?
Share tips

Delivering profits: should you buy Royal Mail shares?

The volume of parcels delivered by Royal Mail soared during the pandemic, and so did its profits. But it has been coming under pressure lately. So, as…
19 May 2022

Most Popular

The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
18 May 2022
Aviva: a share for income investors to tuck away
Share tips

Aviva: a share for income investors to tuck away

Insurance giant Aviva is one of the highest yielding stocks in the FTSE 100 – and it’s cheap, too, making it a tempting target for income investors. R…
18 May 2022
Despite the crypto crash, bitcoin still has a bright future
Bitcoin & crypto

Despite the crypto crash, bitcoin still has a bright future

Cryptocurrencies have crashed hard, with bitcoin down by more than 50% from its peak. But, says Dominic Frisby, bitcoin still has a future – it is the…
19 May 2022